Tengonermin (ARENEGYR) 是一种血管靶向剂，由与CNGRCG肽结合的人肿瘤坏死因子-α (TNF-α) 组成。Tengonermin 通过改变肿瘤微环境来增加肿瘤内化疗的渗透和 T 细胞浸润。
| 生物活性 | Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the humanTumour Necrosis Factor-α (TNF-α)conjugated with theCNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment[1][2]. |
体外研究
(In Vitro) | NGR-hTNF 是一种实体瘤治疗剂，通过 NGR 基序特异性靶向血管生成肿瘤血管[1]。
|
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com